Drug Shortage Report for TEVA-CARBAMAZEPINE

Last updated on 2019-05-28 History
Report ID 82410
Drug Identification Number 00782718
Brand name TEVA-CARBAMAZEPINE
Common or Proper name CARBAMAZEPINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-04-25
Estimated end date 2019-05-15
Actual end date 2019-05-15
Shortage status Resolved
Updated date 2019-05-28
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-05-28 French Compare
v4 2019-05-28 English Compare
v3 2019-04-26 English Compare
v2 2019-04-25 French Compare
v1 2019-04-25 English Compare